Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that an individual’s quality of life prior to treatment can help predict the overall survival of patients with advanced stage non-small cell lung cancer (NSCLC). For those with advanced stage NSCLC, the median overall survival varies between six and 12 months, with approximately one-third of patients surviving past the one year mark.